Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10481)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
DPP4
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Unspecific Target [Unspecific Target]
In total 1 item(s) under this target | |||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
Responsed Disease | Hereditary Leiomyomatosis | ICD-11: 2C90 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
Cell cycle | |||||
In Vitro Model |
786-O cells | Renal cell carcinoma | Homo sapiens | CVCL_1051 | |
Caki-1 cells | Clear cell renal cell carcinoma | Homo sapiens | CVCL_0234 | ||
A-498 cells | Renal cell carcinoma | Homo sapiens | CVCL_1056 | ||
769-P cells | Renal cell carcinom | Homo sapiens | CVCL_1050 | ||
ACHN cells | Papillary renal cell carcinoma | Homo sapiens | CVCL_1067 | ||
HK-2 cells | Normal | Homo sapiens | CVCL_0302 | ||
In Vivo Model |
Female SCID mice (4-6 weeks old) were purchased and used for the xenograft models. Approximately 5 x 106 ccRCC cells were injected subcutaneously into the flank. The mice were treated with vehicle (control) or chaetocin (0.5 mg/kg/day) by daily intraperitoneal injection.
Click to Show/Hide
|
||||
Response regulation | SUV39H1 expression is frequently upregulated in clear cell renal cell carcinoma (ccRCC) tumors and is significantly correlated with ccRCC progression. Function loss of SUV39H1 in ccRCC tumors contributes the hypomethylation of the DPP4 promoter to upregulate DPP4 expression and induces DPP4-mediated ferroptosis to suppress cell proliferation. | ||||
Hereditary Leiomyomatosis [ICD-11: 2C90]
In total 1 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
Target Regulator | Dipeptidyl peptidase 4 (DPP4) | Protein coding | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
Cell cycle | |||||
In Vitro Model |
786-O cells | Renal cell carcinoma | Homo sapiens | CVCL_1051 | |
Caki-1 cells | Clear cell renal cell carcinoma | Homo sapiens | CVCL_0234 | ||
A-498 cells | Renal cell carcinoma | Homo sapiens | CVCL_1056 | ||
769-P cells | Renal cell carcinom | Homo sapiens | CVCL_1050 | ||
ACHN cells | Papillary renal cell carcinoma | Homo sapiens | CVCL_1067 | ||
HK-2 cells | Normal | Homo sapiens | CVCL_0302 | ||
In Vivo Model |
Female SCID mice (4-6 weeks old) were purchased and used for the xenograft models. Approximately 5 x 106 ccRCC cells were injected subcutaneously into the flank. The mice were treated with vehicle (control) or chaetocin (0.5 mg/kg/day) by daily intraperitoneal injection.
Click to Show/Hide
|
||||
Response regulation | SUV39H1 expression is frequently upregulated in clear cell renal cell carcinoma (ccRCC) tumors and is significantly correlated with ccRCC progression. Function loss of SUV39H1 in ccRCC tumors contributes the hypomethylation of the DPP4 promoter to upregulate DPP4 expression and induces DPP4-mediated ferroptosis to suppress cell proliferation. | ||||